OKYO Pharma Limited
OKYO
$2.42
$0.052.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.56M | 1.56M | 987.20K | 987.20K | 826.80K |
| Total Receivables | 1.89M | 1.89M | 1.52M | 1.52M | 580.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 225.40K | 225.40K | 319.40K | 319.40K | 130.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 4.50K | 4.50K | -- |
| Total Current Assets | 3.68M | 3.68M | 2.83M | 2.83M | 1.54M |
|
|
|||||
| Total Current Assets | 3.68M | 3.68M | 2.83M | 2.83M | 1.54M |
| Net Property, Plant & Equipment | 2.00K | 2.00K | 2.20K | 2.20K | 3.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 3.68M | 3.68M | 2.83M | 2.83M | 1.54M |
|
|
|||||
| Total Accounts Payable | 7.90M | 7.90M | 9.61M | 9.61M | 6.13M |
| Total Accrued Expenses | 1.24M | 1.24M | -- | -- | 1.19M |
| Short-term Debt | -- | -- | 1.80K | 1.80K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 89.00K | 89.00K | 445.60K | 445.60K | 103.80K |
| Total Other Current Liabilities | 89.00K | 89.00K | 445.60K | 445.60K | 103.80K |
| Total Current Liabilities | 9.23M | 9.23M | 10.05M | 10.05M | 7.42M |
|
|
|||||
| Total Current Liabilities | 9.23M | 9.23M | 10.05M | 10.05M | 7.42M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 1.80K | 1.80K | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.23M | 9.23M | 10.05M | 10.05M | 7.42M |
|
|
|||||
| Common Stock & APIC | 146.72M | 146.72M | 144.05M | 144.05M | 143.11M |
| Retained Earnings | -143.03M | -143.03M | -145.20M | -145.20M | -142.52M |
| Treasury Stock & Other | -9.24M | -9.24M | -6.07M | -6.07M | -6.47M |
| Total Common Equity | -5.55M | -5.55M | -7.23M | -7.23M | -5.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.55M | -5.55M | -7.23M | -7.23M | -5.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.55M | -5.55M | -7.23M | -7.23M | -5.88M |
|
|
|||||